Strategic partnerships RiconPharma has active development and manufacturing partnerships across the US, Canada, Europe, and India, presenting an opportunity to propose co-development or contract manufacturing collaborations for Transdermal Patch and Solid Oral products.

Transdermal focus With explicit interest in Transdermal Patch development and commercialization, target patients and brands seeking patch-based delivery to introduce or accelerate their portfolio through RiconPharma's expertise and facilities.

Global reach Dual-site operations in the US and India combined with a broad partner network position RiconPharma to handle global regulatory, QA/QC, and manufacturing needs for international clients seeking scalable production.

Financial scope Revenue range of 25–50 million suggests mid-market collaboration potential for CDMO services, including early-stage development, scale-up, and regulatory support for mid-sized pharma and specialty companies.

IP and risk Past legal activity around patents highlights the importance of proactive IP diligence; approach opportunities with clear patent landscapes and risk assessments to align with partner and customer expectations.